Orbimed Capital Gp Vii Llc - Net Worth and Insider Trading

Over the past 18 months, Orbimed Capital Gp Vii Llc made no insider transaction in Arcutis Biotherapeutics Inc (ARQT). Other recent insider transactions involving Arcutis Biotherapeutics Inc (ARQT) include a net sale of 103,828 shares made by Patrick Burnett , a net sale of 57,000 shares made by Howard G. Welgus , and a net sale of 19,451 shares made by Masaru Matsuda .

In summary, during the past 3 months, insiders sold 64,641 shares of Arcutis Biotherapeutics Inc (ARQT) in total and bought 0 shares, with a net sale of 64,641 shares. During the past 18 months, 241,706 shares of Arcutis Biotherapeutics Inc (ARQT) were sold and 102,515 shares were bought by its insiders, resulting in a net sale of 139,191 shares.

Arcutis Biotherapeutics Inc (ARQT)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Pandion Therapeutics Inc (PAND) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Pandion Therapeutics Inc (PAND) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Pandion Therapeutics Inc (PAND)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Fusion Pharmaceuticals Inc (FUSN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Fusion Pharmaceuticals Inc (FUSN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Fusion Pharmaceuticals Inc (FUSN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Orbimed Capital Gp Vii Llc made no insider transaction in Repare Therapeutics Inc (RPTX). Other recent insider transactions involving Repare Therapeutics Inc (RPTX) include a net sale of 12,683 shares made by Michael Zinda , a net purchase of 2,011,010 shares made by Biotechnology Value Fund L P , and a net sale of 13,091 shares made by Lloyd Mitchell Segal .

In summary, during the past 3 months, insiders sold 0 shares of Repare Therapeutics Inc (RPTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 32,163 shares of Repare Therapeutics Inc (RPTX) were sold and 2,011,010 shares were bought by its insiders, resulting in a net purchase of 1,978,847 shares.

Repare Therapeutics Inc (RPTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Orbimed Capital Gp Vii Llc made no insider transaction in Keros Therapeutics Inc (KROS). Other recent insider transactions involving Keros Therapeutics Inc (KROS) include a net sale of 80,000 shares made by Keith Regnante , a net sale of 250,000 shares made by Orbimed Advisors Llc , and a net sale of 250,000 shares made by Carl L Gordon .

In summary, during the past 3 months, insiders sold 500,000 shares of Keros Therapeutics Inc (KROS) in total and bought 0 shares, with a net sale of 500,000 shares. During the past 18 months, 580,000 shares of Keros Therapeutics Inc (KROS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 580,000 shares.

Keros Therapeutics Inc (KROS)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Imara Inc (IMRA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Imara Inc (IMRA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Imara Inc (IMRA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Orbimed Capital Gp Vii Llc made no insider transaction in Passage Bio Inc (PASG). Other recent insider transactions involving Passage Bio Inc (PASG) include a net purchase of 992,446 shares made by Orbimed Advisors Llc , a net sale of 13,506 shares made by Simona King , and a net sale of 4,052 shares made by Alexandros Fotopoulos .

In summary, during the past 3 months, insiders sold 200,131 shares of Passage Bio Inc (PASG) in total and bought 0 shares, with a net sale of 200,131 shares. During the past 18 months, 220,797 shares of Passage Bio Inc (PASG) were sold and 1,192,577 shares were bought by its insiders, resulting in a net purchase of 971,780 shares.

Passage Bio Inc (PASG)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Sierra Oncology Inc (SRRA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sierra Oncology Inc (SRRA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Sierra Oncology Inc (SRRA)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Synthorx Inc (THOR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Synthorx Inc (THOR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Synthorx Inc (THOR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Orbimed Capital Gp Vii Llc made no insider transaction in Theseus Pharmaceuticals Inc (THRX). Other recent insider transactions involving Theseus Pharmaceuticals Inc (THRX) include a net purchase of 700,000 shares made by Foresite Capital Fund V, L.p. , a net purchase of 479,932 shares made by Orbimed Advisors Llc , and a net purchase of 479,932 shares made by Carl L Gordon .

In summary, during the past 3 months, insiders sold 0 shares of Theseus Pharmaceuticals Inc (THRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Theseus Pharmaceuticals Inc (THRX) were sold and 1,659,864 shares were bought by its insiders, resulting in a net purchase of 1,659,864 shares.

Theseus Pharmaceuticals Inc (THRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Orbimed Capital Gp Vii Llc made no insider transaction in Kinnate Biopharma Inc (KNTE). Other recent insider transactions involving Kinnate Biopharma Inc (KNTE) include a net purchase of 2,866,100 shares made by Orbimed Advisors Llc , a net purchase of 2,866,100 shares made by Carl L Gordon , and a net purchase of 1,780,000 shares made by Foresite Capital Fund Iv, L.p. .

In summary, during the past 3 months, insiders sold 0 shares of Kinnate Biopharma Inc (KNTE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Kinnate Biopharma Inc (KNTE) were sold and 9,292,200 shares were bought by its insiders, resulting in a net purchase of 9,292,200 shares.

Kinnate Biopharma Inc (KNTE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Orbimed Capital Gp Vii Llc made no insider transaction in Galecto Inc (GLTO). Other recent insider transactions involving Galecto Inc (GLTO) include a net sale of 1,504,628 shares made by Orbimed Advisors Llc ,

In summary, during the past 3 months, insiders sold 0 shares of Galecto Inc (GLTO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 60,185 shares of Galecto Inc (GLTO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 60,185 shares.

Galecto Inc (GLTO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Orbimed Capital Gp Vii Llc made no insider transaction in Janux Therapeutics Inc (JANX). Other recent insider transactions involving Janux Therapeutics Inc (JANX) include a net sale of 1,343,419 shares made by Avalon Ventures Xi, L.p. , a net sale of 650,146 shares made by Jay Lichter , and a net purchase of 27,133 shares made by Tighe Reardon .

In summary, during the past 3 months, insiders sold 693,273 shares of Janux Therapeutics Inc (JANX) in total and bought 0 shares, with a net sale of 693,273 shares. During the past 18 months, 4,515,994 shares of Janux Therapeutics Inc (JANX) were sold and 3,044,570 shares were bought by its insiders, resulting in a net sale of 1,471,424 shares.

Janux Therapeutics Inc (JANX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Orbimed Capital Gp Vii Llc made no insider transaction in Terns Pharmaceuticals Inc (TERN). Other recent insider transactions involving Terns Pharmaceuticals Inc (TERN) include a net purchase of 5,531 shares made by Mark J. Vignola , a net sale of 47,000 shares made by Jill M. Quigley , and a net purchase of 15,531 shares made by Seokho Bryan Yoon .

In summary, during the past 3 months, insiders sold 169,328 shares of Terns Pharmaceuticals Inc (TERN) in total and bought 476,190 shares, with a net purchase of 306,862 shares. During the past 18 months, 589,991 shares of Terns Pharmaceuticals Inc (TERN) were sold and 509,363 shares were bought by its insiders, resulting in a net sale of 80,628 shares.

Terns Pharmaceuticals Inc (TERN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Orbimed Capital Gp Vii Llc made no insider transaction in Third Harmonic Bio Inc (THRD). Other recent insider transactions involving Third Harmonic Bio Inc (THRD) include a net sale of 25,114 shares made by , a net sale of 23,970 shares made by Julie Person , and a net sale of 33,780 shares made by Natalie C. Holles .

In summary, during the past 3 months, insiders sold 10,000 shares of Third Harmonic Bio Inc (THRD) in total and bought 0 shares, with a net sale of 10,000 shares. During the past 18 months, 87,654 shares of Third Harmonic Bio Inc (THRD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 87,654 shares.

Third Harmonic Bio Inc (THRD)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Orbimed Capital Gp Vii Llc made no insider transaction in Enliven Therapeutics Inc (ELVN). Other recent insider transactions involving Enliven Therapeutics Inc (ELVN) include a net sale of 193,979 shares made by Samuel Kintz , a net sale of 177,099 shares made by Joseph P Lyssikatos , and a net sale of 62,991 shares made by Benjamin Hohl .

In summary, during the past 3 months, insiders sold 151,271 shares of Enliven Therapeutics Inc (ELVN) in total and bought 0 shares, with a net sale of 151,271 shares. During the past 18 months, 4,703,140 shares of Enliven Therapeutics Inc (ELVN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 4,703,140 shares.

Enliven Therapeutics Inc (ELVN)'s detailed insider trading history can be found in Insider Trading Tracker table.